Iranian researchers have discovered that the side effects of the drug Mitoxantrone could be reduced when the chemotherapeutic agent is infused with liposomic nanocarriers.
Iranian scientists have successfully reduced the side effects of a cancer drug by infusing it with nanotechnology.
Researchers at the Tabriz University of Medical Sciences discovered that the side effects of the drug Mitoxantrone could be reduced when the chemotherapeutic agent is infused with liposomic nanocarriers, which are created with cholesterol derivatives, IRNA reported on Tuesday.
Mitoxantrone is a cancer drug that disrupts DNA synthesis and DNA repair in both healthy cells and cancer cells, and is used to treat certain types of cancer such as metastatic breast cancer, acute myeloid leukemia, and non-Hodgkin’s lymphoma.
The produced “nanoliposomes,” apart from being stable to pH changes in blood plasma, have proven to be more poisonous to cancer cells than to normal cells, which would reduce the required dosage and side effects, said head of the research team Dr. Saeed Qanbarzadeh.
The most common side effects of Mitoxantrone, which hinder its wider spread use, are nausea, vomiting, hair loss, heart damage, and immunosuppression.
For the first time in Iran's aviation history, a flight carrying an all-female crew and…
Tehran’s Cyber Police Chief, Brigadier General Davood Moazzami Goudarzi, announced a crackdown on individuals causing…
Doha will stop gas shipments to the EU if member states enforce new legislation on…
At least 15,000 British soldiers left the country's Armed Forces between November 2023 and October…
Journalists have identified the names of 84,761 Russian soldiers who died during the war in…
The United States Navy has inadvertently shot down its own F/A-18 fighter jet in a…